Insigneo
Professor Jim Wild is the Executive Director at the Insigneo Institute for in silico Medicine.
He is a Magnetic Resonance Physicist who joined the University of Sheffield in 2000 to set up the technology for hyperpolarised gas lung Magnetic Resonance Imaging (MRI).
Jim’s research focuses on the physics and engineering and clinical applications of hyperpolarised gas (3He and 129Xe) and proton MRI in the lungs and pulmonary vasculature.
His research has demonstrated the role of these pulmonary MRI methods in Asthma, COPD, Cystic Fibrosis, Interstitial Lung Disease, Lung cancer and Pulmonary Hypertension.
Using hyperpolarised gas and proton lung MRI, he is evaluating novel pulmonary therapies in collaboration with pharmaceutical companies. The lung imaging methods and models are the basis of patient specific in silico models of lung disease at Insigneo in VPH projects such as Airprom.
This person is not in any offices
Insigneo
The Insigneo Institute for in silico medicine is a collaborative initiative between the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust. It is a multi-disciplinary institute involving over 140 academics and clinicians who collaborate to develop computer simulations of the human body and its disease processes that can be used directly in clinical practice to improve diagnosis and treatment.